Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

NCT07618338 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT07618338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07618338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia
Lead sponsor
Dokuz Eylul University
Phase
Not applicable
Overall status
Completed
Start date
September 17, 2018
Completion date
January 15, 2020
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia disorder